International Journal of Infectious Diseases, 2019 Objective: To assess the long-term safety of MF59-adjuvanted trivalent influenza vaccine (aIIV3; Fluad™) in adults ≥65 years of age. Methods: Data from 36 primary vaccination and 7 re-vaccination Phase I through III trials were analyzed; 7532 subjects ...
Kelly Lindert +4 more
doaj +1 more source
Impfungen gegen Pneumokokken und Influenza: Wie groß ist die Evidenz? [PDF]
, 2018 Zusammenfassung: Durch Pneumokokken verursachte Infektionen und die Influenza können bei Kindern und älteren Personen sowie bei chronisch Kranken und Immunosupprimierten zu schweren, komplizierten Verläufen führen.
Babouee, B., Battegay, M., Widmer, A.F.
core
Poly(Anhydride) Nanoparticles Act as Active Th1 Adjuvants through Toll-Like Receptor Exploitation [PDF]
, 2010 The mechanisms that underlie the potent Th1-adjuvant capacity of poly(methyl vinyl ether-co-maleic anhydride) nanoparticles (NPs) were investigated.
Gamazo, C. (Carlos) +5 more
core
Epitope-specific humoral responses to human cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in seropositive solid organ transplant recipients: anti-AD2 levels correlate with protection from viraemia [PDF]
, 2018 The human cytomegalovirus (HCMV) virion envelope protein glycoprotein B (gB) is essential for viral entry and represents a major target for humoral responses following infection.
Baraniak, IA +8 more
core
VaccinesMF59 and AS03 are squalene emulsion-based vaccine adjuvants with similar compositions and droplet sizes. Despite their broad use in licensed influenza vaccines, few studies compared their adjuvant effects and action mechanisms side by side.
Jayachandra Reddy Nakkala +4 more
doaj +1 more source
Aqueous extract of Calamus rotang as a novel immunoadjuvant enhances both humoral and cell mediated immune response [PDF]
, 2017 Introduction: Search for new adjuvants for human vaccines has become an expanding field of research in the last thirty years for generating stronger vaccines, capable of inducing protective and long lasting immunity in humans. The objective of this study
Chaphalkar, S.R. +2 more
core
MF59 adjuvanted seasonal and pandemic influenza vaccines.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012 MF59-adjuvanted seasonal trivalent inactivated (ATIV) vaccine licensed since 1997 and MF59-adjuvanted pandemic H1N1 vaccines have been distributed to approximately 80M persons. Addition of the emulsion adjuvant to inactivated vaccine formulations provides for higher levels of antibody to the viral hemagglutinin (HA) in less responsive older adults ...
openaire +1 more source
Control of Vulval Cell Division Number in the Nematode Oscheius/Dolichorhabditis sp. CEW1 [PDF]
, 2001 Spatial patterning of vulval precursor cell fates is achieved through a different two-stage induction mechanism in the nematode Oscheius/Dolichorhabditis sp. CEW1 compared with Caenorhabditis elegans.
Dichtel, Marie-Laure +4 more
core
Seroprevalence to cytomegalovirus in the Portuguese population, 2002-2003 [PDF]
, 2011 The prevalence of cytomegalovirus (CMV) infections ranges between 50% and 85% in adults in the United States, and its epidemiology varies in different regions of the world and between socioeconomic and age groups.
Freitas, Maria Graça +5 more
core +1 more source
Correlation of influenza infection with glycan array [PDF]
, 2012 Poster Presentation: SPB1 / SPB2 - Virus Host Interaction/Pathogensis/Transmission: abstract no. B109PINTRODUCTION: The past 6 years has seen the introduction of glycan arrays containing large numbers of sialic acid (Sia) containing compounds and these ...
Air, G +9 more
core